Cerebrospinal fluid cortisol levels are higher in patients with delirium versus controls
© MacLullich et al; licensee BioMed Central Ltd. 2010
Received: 17 March 2009
Accepted: 8 February 2010
Published: 8 February 2010
High plasma cortisol levels can cause acute cognitive and neuropsychiatric dysfunction, and have been linked with delirium. CSF cortisol levels more closely reflect brain exposure to cortisol, but there are no studies of CSF cortisol levels in delirium. In this pilot study we acquired CSF specimens at the onset of spinal anaesthesia in patients undergoing hip fracture surgery, and compared CSF and plasma cortisol levels in delirium cases versus controls.
Delirium assessments were performed the evening before or on the morning of operation with a standard battery comprising cognitive tests, mental status assessments and the Confusion Assessment Method. CSF and plasma samples were obtained at the onset of the operation and cortisol levels measured. Twenty patients (15 female, 5 male) aged 62 - 93 years were studied. Seven patients were diagnosed with delirium. The mean ages of cases (81.4 (SD 7.2)) and controls (80.5 (SD 8.7)) were not significantly different (p = 0.88). The median (interquartile range) CSF cortisol levels were significantly higher in cases (63.9 (40.4-102.1) nmol/L) than controls (31.4 (21.7-43.3) nmol/L; Mann-Whitney U, p = 0.029). The median (interquartile range) of plasma cortisol was also significantly higher in cases (968.8 (886.2-1394.4) nmol/L, than controls (809.4 (544.0-986.4) nmol/L; Mann Whitney U, p = 0.036).
These findings support an association between higher CSF cortisol levels and delirium. This extends previous findings linking higher plasma cortisol and delirium, and suggests that more definitive studies of the relationship between cortisol levels and delirium are now required.
Delirium is a severe neuropsychiatric syndrome with core features of acute onset and fluctuating course of inattention. It mainly affects older people, particularly those with chronic cognitive impairment, and is commonly precipitated by acute illness, surgery, trauma or by the effects of drugs . Delirium occurs in approximately 15% of older medical inpatients and in at least one third of patients after hip fracture . However, the mechanisms of delirium are under-researched and poorly understood .
Several lines of evidence support the hypothesis that high levels of cortisol may play a role in the pathophysiology of delirium [3, 4]. Animals given high doses of glucocorticoids show cognitive deficits . In experimental studies and clinical practice, high doses of cortisol or other glucocorticoids can cause inattention and other cognitive deficits [5–8]. Most patients with Cushing's disease, in which there are sustained high levels of cortisol, show neuropsychological impairments . Ageing, a major risk factor for delirium, is associated with dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis. This dysregulation results in higher glucocorticoid levels under basal and stressed conditions, and slower return of cortisol to baseline levels following stress [5, 10, 11]. Importantly, HPA axis dysregulation is pronounced in patients with dementia , who are at greatly increased risk of delirium . Further, there is direct evidence that high plasma cortisol or HPA axis dysregulation occur in patients with delirium [3, 4]. In patients aged 70-90 years undergoing abdominal surgery, those who developed delirium had substantially (>30%) higher plasma cortisol levels immediately, 24 and 48 hours after surgery . O'Keeffe and Devlin  examined the relationship between delirium and the dexamethasone suppression test in 16 elderly patients with pneumonia. In this test, non-suppression of cortisol levels after a single dose of dexamethasone indicates dysregulation of the HPA axis. Seven of the nine patients with delirium and only one of the seven non-delirious patients were non-suppressors.
There are no published studies which have examined links between cerebrospinal fluid (CSF) cortisol levels and delirium. Determining CSF cortisol levels is potentially important because they provide a more direct and less variable measure of brain cortisol exposure than plasma levels, and because CSF cortisol levels are only variably related to plasma levels . CNS cortisol levels are modified by multiple factors including the degree of blood brain permeability , the activity of the multidrug-resistance gene type-1 P-glycoprotein , and steroid metabolising enzymes within the brain, such as 11β-hydroxysteroid dehydrogenase type 1 .
More generally, there are very few studies which have examined CSF in delirium [19–21], despite the obvious value of such studies. This may be partly because that obtaining CSF samples in such patients presents considerable ethical and practical challenges. One method which avoids many of these challenges is to obtain CSF samples in patients with hip fracture, who have a high prevalence of delirium, at the time of induction of spinal anaesthesia for fracture repair. CSF collection at the time of spinal anaesthesia has been used in one study on hip fracture patients , which found higher CSF IL-8 levels in hip fracture patients versus elective arthroplasty controls, but has not yet been used in the study of delirium.
In the present study we tested the hypothesis that delirium is associated with higher CSF and plasma cortisol levels in older patients with acute hip fracture.
We studied patients with acute hip fracture over 60 years old who were awaiting surgery under spinal anaesthesia. Patients gave written, informed consent. Exclusion criteria were residence in an institution, a documented history of dementia or depressive illness, and corticosteroid therapy within the last 10 weeks. The study was approved by the Scotland A Research Ethics Committee.
Delirium assessments were performed pre-operatively, no more than 16 hours before the operation, and before any pre-operative sedative medication. Each assessment comprised a standard battery of scales (Mini-Mental State Examination, digit span, the Delirium Symptom Interview, the Memorial Delirium Assessment Scale and the Confusion Assessment Method) validated for the diagnosis of delirium . In this battery these combined assessments are used to complete the standard and widely-used Confusion Assessment Method (CAM), an established instrument for the detection of delirium . The CAM comprises a four-point algorithm for delirium diagnosis. For a positive diagnosis patients have to show (a) an acute onset or fluctuating course, and (b) inattention, and they must also demonstrate (c) disorganised thinking and/or (d) altered arousal. The comprehensive, validated battery we used allows each of these features to be defined, through a combination of patient assessments (interview, clinical observation, and cognitive testing), and information from staff, carers, and casenotes.
Sample Collection and Assays
Samples of CSF (2 ml) and clotted blood (10 ml) were taken before administration of the spinal anaesthestic agent. Samples were spun at 1000 g for 10 minutes at 4°C. To check for blood contamination in the CSF, the pellet was resuspended in 100 ul phosphate buffer saline followed by a cytospin. All samples were stored at -80°C before analysis. Plasma cortisol assays were performed with a Cortisol-125I RIA (ImmunChem™, MP Biomedicals), with a detection limit of 22.4 nmol/l. CSF cortisol levels were determined with a cortisol ELISA kit (Salimetrics, USA). The detection range for this kit is 0.08 - 82.8 nmol/L.
Group differences in cortisol levels were analysed with the Mann-Whitney U test (two-tailed). Non-parametric correlation (Spearman's rho) was used to examine the relationship between CSF and plasma cortisol levels.
Subject characteristics, and cerebrospinal fluid and plasma cortisol levels
CSF cortisol (nmol/L)
Plasma cortisol (nmol/L)
IHD, type 2 DM
IHD, type 2 DM
Plasma and CSF cortisol levels correlated at rho = 0.59 (p = 0.006). The ratios of CSF to plasma cortisol were not statistically different between the groups (Mann Whitney U, p = 0.122).
The novel finding in this study was that CSF cortisol levels were significantly higher in hip fracture patients with delirium versus controls. Plasma cortisol levels were also significantly higher in cases versus controls. The direction of causation cannot be determined in an observational study, but these findings are consistent with the hypothesis that high brain cortisol levels are associated with delirium.
Higher levels of cortisol occurring after hip fracture are an essential part of the systemic response to injury. Consistent with this, the CSF cortisol levels in the present study were generally considerably higher than those in healthy younger control subjects (mean 12.3, SEM 1.26), in healthy older people (mean 8.3, SEM 0.55), or in patients with Alzheimer's disease (mean = 21.90, SD = 8.1); the levels were around half of those in patients with septic meningitis (median 133 nmol/L (interquartile range 59-278). Two patients with delirium had extremely high CSF cortisol levels (cases 4 and 7), of 102.1 and 245.0 nmol/L. The causes of this degree of elevation is uncertain, but very high plasma cortisol levels of several thousand nmol/L are commonly observed in critically ill patients . These extreme levels may reflect the severity of illness in combination with loss of feedback regulation.
There is good evidence that the degree of elevation of cortisol, even within the 'stress' range, is important in causing cognitive dysfunction. For example, in healthy young males, high doses of administered cortisol over four days (reaching plasma levels of 700-800 nmol/L) caused verbal memory impairment  and in another study continuous infusion of high-dose cortisol caused impairments in working memory . Thus, although elevated levels of cortisol are a critical component of the physiological response to injury, pathologically high cortisol levels might be more likely to impair cognitive functioning, and even precipitate delirium in vulnerable patients . Another important factor may be individual differences in vulnerability to cortisol-induced cognitive dysfunction . Indeed, in this study levels of cortisol in cases and controls showed some overlap.
Some limitations of the study should be noted. The sample size was relatively small. Dementia is a risk factor for delirium and is also associated with higher CSF cortisol levels, and so is a potential confounder, though in the present study patients with known dementia were excluded. However, future studies would benefit from more detailed screening of patients, and retrospective informant history, for example with the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE). CSF sampling occurred at different times of the day; however this may not be important because of the loss of diurnal rhythm of cortisol in the early phase after a fracture . Another limitation is that some delirium assessments took place the evening before surgery, several hours before the cortisol measurements. Future studies should aim to conduct these assessments and measurements as close together as possible. Additionally, possible interactions between drugs known to precipitate delirium, and cortisol levels, should be explored.
These results suggest that patients with delirium have higher levels of cortisol in the CSF and plasma. Should a causal role for cortisol be established, this would suggest a potential role for antiglucocorticoid therapies in delirium.
chronic obstructive pulmonary disease
ischaemic heart disease
- type 2 DM:
type 2 diabetes mellitus.
This study was funded by an MRC Clinician Scientist Fellowship to AM. The work was undertaken by the University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative. Funding from the BBSRC, EPSRC, ESRC and MRC is gratefully acknowledged.
- Young J, Inouye SK: Delirium in older people. British Medical Journal. 2007, 334: 842-846D. 10.1136/bmj.39169.706574.AD.PubMed CentralPubMedView ArticleGoogle Scholar
- Siddiqi N, House AO, Holmes JD: Occurrence and outcome of delirium in medical in-patients: a systematic literature review. Age Ageing. 2006, 35: 350-364. 10.1093/ageing/afl005.PubMedView ArticleGoogle Scholar
- MacLullich AMJ, Ferguson KJ, Miller T, de Rooij SEJA, Cunningham C: Unravelling the pathophysiology of delirium: A focus on the role of aberrant stress responses. Journal of Psychosomatic Research. 2008, 65: 229-238. 10.1016/j.jpsychores.2008.05.019.PubMed CentralPubMedView ArticleGoogle Scholar
- Olsson T: Activity in the hypothalamic-pituitary-adrenal axis and delirium. Dementia and Geriatric Cognitive Disorders. 1999, 10: 345-349. 10.1159/000017168.PubMedView ArticleGoogle Scholar
- Herbert J, Goodyer IM, Grossman AB, Hastings MH, de Kloet ER, Lightman SL: Do corticosteroids damage the brain?. Journal of Neuroendocrinology. 2006, 18: 393-411. 10.1111/j.1365-2826.2006.01429.x.PubMedView ArticleGoogle Scholar
- Lupien SJ, Gillin CJ, Hauger RL: Working memory is more sensitive than declarative memory to the acute effects of corticosteroids: A dose-response study in humans. Behavioral Neuroscience. 1999, 113: 420-430. 10.1037/0735-7044.113.3.420.PubMedView ArticleGoogle Scholar
- Sirois F: Steroid psychosis: a review. General Hospital Psychiatry. 2003, 25: 27-33. 10.1016/S0163-8343(02)00241-4.PubMedView ArticleGoogle Scholar
- Newcomer JW, Selke G, Melson AK, Hershey T, Craft S, Richards K: Decreased memory performance in healthy humans induced by stress-level cortisol treatment. Archives of General Psychiatry. 1999, 56: 527-533. 10.1001/archpsyc.56.6.527.PubMedView ArticleGoogle Scholar
- Starkman MN, Giordani B, Berent S, Schork MA, Schteingart DE: Elevated cortisol levels in Cushing's disease are associated with cognitive decrements. Psychosomatic Medicine. 2001, 63: 985-993.PubMedView ArticleGoogle Scholar
- MacLullich AM, Deary IJ, Starr JM, Ferguson KJ, Wardlaw JM, Seckl JR: Plasma cortisol levels, brain volumes and cognition in healthy elderly men. Psychoneuroendocrinology. 2005, 30: 505-515. 10.1016/j.psyneuen.2004.12.005.PubMedView ArticleGoogle Scholar
- MacLullich AM, Ferguson KJ, Wardlaw JM, Starr JM, Deary IJ, Seckl JR: Smaller left anterior cingulate cortex volumes are associated with impaired hypothalamic-pituitary-adrenal axis regulation in healthy elderly men. J Clin Endocrinol Metab. 2006, 91: 1591-1594. 10.1210/jc.2005-2610.PubMedView ArticleGoogle Scholar
- Deleon MJ, Mcrae T, Tsai JR, George AE, Marcus DL, Freedman M: Abnormal Cortisol Response in Alzheimer's-Disease Linked to Hippocampal Atrophy. Lancet. 1988, 2: 391-392. 10.1016/S0140-6736(88)92855-3.View ArticleGoogle Scholar
- Kudoh A, Takase H, Katagai H, Takazawa T: Postoperative interleukin-6 and cortisol concentrations in elderly patients with postoperative confusion. Neuroimmunomodulation. 2005, 12: 60-66. 10.1159/000082365.PubMedView ArticleGoogle Scholar
- O'Keeffe ST, Devlin JG: Delirium and the Dexamethasone Suppression Test in the Elderly. Neuropsychobiology. 1994, 30: 153-156. 10.1159/000119154.PubMedView ArticleGoogle Scholar
- Guazzo EP, Kirkpatrick PJ, Goodyer IM, Shiers HM, Herbert J: Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: Relation to blood levels and the effects of age. Journal of Clinical Endocrinology and Metabolism. 1996, 81: 3951-3960. 10.1210/jc.81.11.3951.PubMedGoogle Scholar
- Esposito P, Gheorghe D, Kandere K, Pang XZ, Connolly R, Jacobson S: Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells. Brain Research. 2001, 888: 117-127. 10.1016/S0006-8993(00)03026-2.PubMedView ArticleGoogle Scholar
- Uhr M, Holsboer F, Muller MB: Penetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice deficient for both mdr1a and mdr1b P-glycoproteins. Journal of Neuroendocrinology. 2002, 14: 753-759. 10.1046/j.1365-2826.2002.00836.x.PubMedView ArticleGoogle Scholar
- Sandeep TC, Yau JLW, MacLullich AMJ, Noble J, Deary IJ, Walker BR: 11 beta-Hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics. Proceedings of the National Academy of Sciences of the United States of America. 2004, 101: 6734-6739. 10.1073/pnas.0306996101.PubMed CentralPubMedView ArticleGoogle Scholar
- Koponen H, Leinonen E, Lepola U: A Longitudinal-Study of CSF Beta-Endorphin in Delirium. Neuropsychopharmacology. 1993, 9: S127-Google Scholar
- Katsumata Y, Harigai M, Kawaguchi Y, Fukasawa C, Soejima M, Takagi K: Diagnostic reliability of cerebral spinal fluid tests for acute confusional state (delirium) in patients with systemic lupus erythematosus: Interleukin 6 (IL-6), IL-8, interferon-alpha, IgG index, and Q-albumin. Journal of Rheumatology. 2007, 34: 2010-2017.PubMedGoogle Scholar
- Ramirez-Bermudez J, Ruiz-Chow A, Perez-Neri I, Soto-Hernandez JL, Flores-Hernandez R, Nente F: Cerebrospinal fluid homovanillic acid is correlated to psychotic features in neurological patients with delirium. General Hospital Psychiatry. 2008, 30: 337-343. 10.1016/j.genhosppsych.2008.01.007.PubMedView ArticleGoogle Scholar
- Chuang D, Power SE, Dunbar PR, Hill AG: Central nervous system interleukin-8 production following neck of femur fracture. Anz Journal of Surgery. 2005, 75: 813-816. 10.1111/j.1445-2197.2005.03530.x.PubMedView ArticleGoogle Scholar
- Simon SE, Bergmann MA, Jones RN, Murphy KM, Orav EJ, Marcantonio ER: Reliability of a structured assessment for nonclinicians to detect delirium among new admissions to postacute care. Journal of the American Medical Directors Association. 2006, 7: 412-415. 10.1016/j.jamda.2006.02.006.PubMedView ArticleGoogle Scholar
- Inouye SK, Vandyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI: Clarifying Confusion - the Confusion Assessment Method - A New Method for Detection of Delirium. Annals of Internal Medicine. 1990, 113: 941-948.PubMedView ArticleGoogle Scholar
- Murakami K, Nakagawa T, Shozu M, Uchide K, Koike K, Inoue M: Changes with aging of steroidal levels in the cerebrospinal fluid of women. Maturitas. 1999, 33: 71-80. 10.1016/S0378-5122(99)00040-7.PubMedView ArticleGoogle Scholar
- Popp J, Schaper K, Kolsch H, Cvetanovska G, Rommel F, Klingmuller D: CSF cortisol in Alzheimer's disease and mild cognitive impairment. Neurobiology of Aging. 2009, 30: 498-500. 10.1016/j.neurobiolaging.2007.07.007.PubMedView ArticleGoogle Scholar
- Holub M, Beran O, Dzupova O, Hnykova J, Lacinova Z, Prihodova J: Cortisol levels in cerebrospinal fluid correlate with severity and bacterial origin of meningitis. Critical Care. 2007, 11: 10.1186/cc5729.Google Scholar
- Ray DC, Macduff A, Drummond GB, Wilkinson E, Adams B, Beckett GJ: Endocrine measurements in survivors and non-survivors from critical illness. Intensive Care Medicine. 2002, 28: 1301-1308. 10.1007/s00134-002-1427-y.PubMedView ArticleGoogle Scholar
- Jorm AF: A Short-Form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) - Development and Cross-Validation. Psychological Medicine. 1994, 24: 145-153. 10.1017/S003329170002691X.PubMedView ArticleGoogle Scholar
- Horan MA: Aging, Injury and the Hypothalamic-Pituitary-Adrenal Axis. Aging Clock. 1994, 719: 285-290.Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.